Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
A semisynthetic polymer derived from cellulose, inert and viscoelastic with thickening, bioadhesive and solubility enhancing properties.
It is used as a drug coating in order to modify its intestinal release and prolong its effect, in preparations for wounds, as artificial saliva and as a lubricant in the form of eye drops.
Since the last update we have not found published data on its excretion in breastmilk.
Being a cellulose derivative, it is not absorbed in the intestine, or as an ophthalmological preparation (AEMPS 2018), so it is highly unlikely to appear in breastmilk.
Its high molecular weight still makes its excretion in breastmilk unlikely.
It is an inert product that is not metabolized and is devoid of toxicity, lacking systemic side effects.
The manufacturer considers the use of this medication to be safe during breastfeeding (AEMPS 2018, Allergan 2014).